stoxline Quote Chart Rank Option Currency Glossary
  
IQVIA Holdings Inc. (IQV)
224.475  5.035 (2.29%)    07-12 13:12
Open: 220.8
High: 224.77
Volume: 557,700
  
Pre. Close: 219.44
Low: 218.44
Market Cap: 40,899(M)
Technical analysis
2024-07-12 12:51:10 PM
Short term     
Mid term     
Targets 6-month :  262.53 1-year :  306.63
Resists First :  224.77 Second :  262.53
Pivot price 212.36
Supports First :  212.58 Second :  205.05
MAs MA(5) :  215.49 MA(20) :  212.62
MA(100) :  232.53 MA(250) :  220.41
MACD MACD :  -1.2 Signal :  -3.1
%K %D K(14,3) :  81.6 D(3) :  65.8
RSI RSI(14): 63.9
52-week High :  261.73 Low :  167.41
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ IQV ] has closed Bollinger Bands are 12.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 220.1 - 220.97 220.97 - 221.73
Low: 211.62 - 212.69 212.69 - 213.61
Close: 217.57 - 219.34 219.34 - 220.86
Company Description

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

Headline News

Fri, 12 Jul 2024
IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by FDx Advisors Inc. - Defense World

Fri, 12 Jul 2024
Will IQVIA Holdings (IQV) Bounce Back? - Yahoo Finance

Fri, 12 Jul 2024
Private Advisor Group LLC Has $1.19 Million Holdings in IQVIA Holdings Inc. (NYSE:IQV) - Defense World

Thu, 11 Jul 2024
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Thu, 11 Jul 2024
BI Asset Management Fondsmaeglerselskab A S Has $2.07 Million Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat

Thu, 11 Jul 2024
BI Asset Management Fondsmaeglerselskab A S Has $2.07 Million Position in IQVIA Holdings Inc. (NYSE:IQV) - Defense World

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out 182 (M)
Shares Float 181 (M)
Held by Insiders 0.9 (%)
Held by Institutions 90.5 (%)
Shares Short 3,250 (K)
Shares Short P.Month 3,040 (K)
Stock Financials
EPS 7.32
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 34.81
Profit Margin 9 %
Operating Margin 13.9 %
Return on Assets (ttm) 5 %
Return on Equity (ttm) 22.1 %
Qtrly Rev. Growth 2.2 %
Gross Profit (p.s.) 0
Sales Per Share 82.71
EBITDA (p.s.) 15.14
Qtrly Earnings Growth 2 %
Operating Cash Flow 2,250 (M)
Levered Free Cash Flow 1,680 (M)
Stock Valuations
PE Ratio 30.56
PEG Ratio 1.7
Price to Book value 6.43
Price to Sales 2.7
Price to Cash Flow 18.14
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android